Clinical and Experimental Neuroimmunology : Impact Factor & More
pISSN: 1759-1961
Share this on:
Key Metrics
CiteScore 
1
Recommended pre-submission checks
Powered by 
Run standard language and technical checks to improve your manuscript – before you submit
Technical Compliance
Ensure manuscript complies with standard submission guidelines.
Language Quality
Improve clarity, grammar, and academic writing style.
A comprehensive report covering all these checks awaits you.
Topics Covered on Clinical and Experimental Neuroimmunology
Clinical and Experimental Neuroimmunology Journal Specifications
Indexed in the following public directories
Scopus
| Overview | |
| Publisher | Wiley-Blackwell |
Planning to publish in Clinical and Experimental Neuroimmunology ?
Upload your Manuscript to get
- Degree of match
- Common matching concepts
- Additional journal recommendations
Recently Published Papers in Clinical and Experimental Neuroimmunology
Title not available
- 1 May 2026
- Clinical and Experimental Neuroimmunology
Cases of <scp>AQP4</scp> ‐Antibody‐Positive Neuromyelitis Optica Spectrum Disorder Successfully Discontinuing Steroids With Satralizumab Treatment: Considerations on the Method of Tapering for Steroids After the Introduction of Satralizumab
- 20 Mar 2026
- Clinical and Experimental Neuroimmunology
Response to the Letter to the Editor: “Multiple Sclerosis in Morocco: Impact on Patients' Quality of Life”
- 19 Mar 2026
- Clinical and Experimental Neuroimmunology
Issue Information
- 26 Feb 2026
- Clinical and Experimental Neuroimmunology
Divergent Kinetics and Cellular Determinants of Neuroinflammation Across Traumatic, Endotoxin, and Viral Brain Injury
- 1 Feb 2026
- Clinical and Experimental Neuroimmunology
Successful Use of Tocilizumab in a 2‐Year‐Old Girl With Probable C‐ <scp>NORSE</scp> / <scp>FIRES</scp> : A Case Report
- 1 Feb 2026
- Clinical and Experimental Neuroimmunology
Title not available
- 1 May 2026
- Clinical and Experimental Neuroimmunology
Cases of <scp>AQP4</scp> ‐Antibody‐Positive Neuromyelitis Optica Spectrum Disorder Successfully Discontinuing Steroids With Satralizumab Treatment: Considerations on the Method of Tapering for Steroids After the Introduction of Satralizumab
- 20 Mar 2026
- Clinical and Experimental Neuroimmunology
Response to the Letter to the Editor: “Multiple Sclerosis in Morocco: Impact on Patients' Quality of Life”
- 19 Mar 2026
- Clinical and Experimental Neuroimmunology
Issue Information
- 26 Feb 2026
- Clinical and Experimental Neuroimmunology
Divergent Kinetics and Cellular Determinants of Neuroinflammation Across Traumatic, Endotoxin, and Viral Brain Injury
- 1 Feb 2026
- Clinical and Experimental Neuroimmunology
Successful Use of Tocilizumab in a 2‐Year‐Old Girl With Probable C‐ <scp>NORSE</scp> / <scp>FIRES</scp> : A Case Report
- 1 Feb 2026
- Clinical and Experimental Neuroimmunology
FAQs on Clinical and Experimental Neuroimmunology
How many articles did Clinical and Experimental Neuroimmunology publish last year? 
What is Citescore for Clinical and Experimental Neuroimmunology?
Who is the publisher of Clinical and Experimental Neuroimmunology?
